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HUIGGINS, Grand and Brillantes (1961) showed that oral administration of a
singledoseof7,12-dimethylbenz(a)anthracene (DMBA), rapidly induces mammary
cancer in Sprague-Dawley female rats age 50 to 65 days. Sydnor, Butenandt,
Brillantes and Huggins (1962) demonstrated that this does not occur in all rat
strains, but that multiple doses were required to induce a high incidence of cancer
in some strains. The studies reported in this paper are an extension of these ob-
servations. Theyindicate that there are variations among rat strains in respect to
their sensitivity to the carcinogenic effects of DMBA. A high incidence of mam-
mary cancer results if multiple doses are given to the August or Chester Beatty
strains, but the Marshall rats are resistant. They further demonstrate that the
feeding of the pyrimidines, thymine and uracil, affords limited protection against
the carcinogenic action of this hydrocarbon.
METHODS AND MATERIALS
With the exception of the experiment shown in Table V in which Wistar,
August, Sprague-Dawley and Marshall strains were included, experiments were
performed on female rats of the Chester Beatty colony. 7,12-Dimethylbenz(a)-
anthracene (DMBA) (Roche Products) was dissolved in arachis oil and admini-
stered in 1 ml. doses bygastrictubeatfortnightlyintervals. Controlanimalswere
given 1 ml. of arachis oil. In one experiment (Table VI) DMBA and 3-methyl-
cholanthrene (3-MC) dissolved in arachis oil were administered intraperitoneally.
A stock diet* (rat nut cake) or one containing 20 per cent proteint was fed ad
libitum.
* Stock diet (Rat cake nut formula):
Fine bran . . 17-4 Meat and bone meal 9.6
Ground wheat . 17*4 Dried skimmed milk . 14-0
Sussex ground oats 17-4 Dried yeast 12
Ground maize . 8*7 Salt 04
Ground barley . . 8.7 Cod liver oil . 04
White fish meal . . 8
t 20 per cent Protein diet:
Flour . . . . 69-0 Calcium carbonate 1-3
Casein . . . 115 Bemax . 2 5
Milk powder . . 8*8 Yeast . 2-1
Margarine 3*3 Cod liver oil . . 1*5
* Eleanor Roosevelt International Fellow. Present address: Department of Medicine, Univer-
sity of Kentucky Medi-al Center, Lexington, Kentucky,. U.S.A.E. BOYLAND AND K. L. SYDNOR
All animals were housed in metal boxes in a well-lighted room (temperature 18 to
240 C.). Palpation for mammary tumours was begun four weeks following the
first feeding of DMBA and continued 3 or 4 times per week until autopsy. All
rats were observed until death, or for 200 days unless otherwise specified.
RESULTS
Feeding experiments
1. Mammary cancer.-Four groups of rats, age 30, 40, 50 and 60 days, re-
spectively, were fed 15 mg. three times at fortnightly intervals. The results
(Table I) suggest that the Chester Beatty strain rats may be more sensitive when
TABLE I.-Influence of Age on the Incidence of Mammary Cancer in Female Rats
Fed 15 mg. DMBA by Gastric Tube at Fortnightly Intervalsfor 3 Doses
Mammary cancer Induction time
Age at - - (days) Number of
start Number - -- tumours*
(days) of rats % M. AS.E.M. Median Range M. ±S.E.M.
30 8/8 100 42-5±2-7 40 33-56 4- 8±133
40 9/10 90 69 0±10-2 61 42-141 4 0±1-24
50 . 9/10 90 74-5±10-4 63 35-119 2-8±1-45
60 7/10 70 . 82±15-4 66 56-155 1-9±0-4
* Number of tumours was determined by inspection at autopsy 60 days following appearance otf
first palpable tumnour.
the first feeding is given at 30 days of age, as all rats of this group develope(d
tumours. The tumour induction time (number of days elapsing between initial
feeding until the first tumour was palpable) for the latter group was 42-5 ± 2-7
days and the mean number of tumours per rat was 4-8 ± 1-33, in contrast to the
oldest age group in which cancer incidence was 70 per cent, mean tumour induction
time was 82 ± 15-4 days, and the mean number of tumours was 1.9 ± 0.4.
These differences were not statistically significant and may be due to differences
of dose levels. The feeding of a 20 per cent protein diet, which protects these rats
from the carcinogenic action of azo-dyes, did not influence the induction of mam-
mary cancer by DMBA (Table II). The results also indicate there is no significant
difference in the responses in the two age groups when the dose is compared on the
basis of body weight. Increasing the dose further to 25 mg. or more did not alter
TABLE II.-Influence of Diet on Mammary Cancer. Female C.B. Wistar Rats
were Fed DMBA by Gastric Tube at Fortnightly Intervals for 3 Doses
Induction time
Age at DMBA Mammary cancer (days) Number of
start (mg.) tumours*
(days) Diet rat Number % M.±S.E.M. Range M.±S.E.M.
30 . Stock 15 11/11 100 53±5-8 34-99 4-0±1-6
20° Proteiii. 15 10/10 100 49±4-8 27-72 6-3 ±1-32
20% 6-8 . 9/12 75 73±10-6 26-112 1-9±059
50 Stock 15 11/12 92 49±4 5 27-73 . 5 3±1 1
200o Proteiin. 15 . 9/10 90 56±5-5 27-89 5-4+1-2
20% 136/kg. 10/10 100 51±8-5 31-123 7-111-7
* Number of tumours was determinied by inspection at autopsy 30 davs after detection of first
palpable tumour.
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mean inductioin time, mean number of tumours or cancer incidence. On the basis
of these two experiments it may be concluded that the range of optimal sensi-
tivity extends at least from 30 to 60 days and that no protection against mam-
mary cancer was afforded by feeding a 20 per cent protein diet.
Table III presents data obtained when two (instead of three) 15 mg. doses of
DMBA were fed. In contrast to the results of experiments 1 and 2, mean tumour
induction time was lengthened to 87 ± 7-3 days and the number of tumours was
reduced to 2-2 ± 0.61. Two 15 mg. doses seem to be necessary to induce cailcer
in a high percentage of Chester Beatty rats since in another experiment only one
of six rats given a single 15 mg. dose of DMBA developed a solitary tumour at
20 days.
Concomitant administration of thymine (1 per cent dry weight in diet and
0 5 per cent in drinking fluid) exerted a protective influence against the carcino-
genic effects ofDMBA (Table III). In the control group fed 20 per cent protein diet
TABLE III. Influence of Thymine on Carcinogenic Response to DMBA Female
Rats, Age 30 Days, were Fed 15 mg. by Gastric Tube at Fortnightly Intervals
for 2 Doses
Induction time
Mammary (days)
cancer Number of
---&-- - -M. tumours*
Diet Number % ±S.E.M. Median Range M.±S.E.M.
20o% . 11/11 100 . 87±7-3 78 55-120 2-2±0-61
20% protein+1% thymine 6/11 55 . 76±16 58 35-138 1-8±0-39
+ 0.5% thymine in drinking
water
* Nunmber of tumours was determined by inspection at autopsy 150 days after administration of
first dose of DMBA.
and two 15 mg. doses of DMBA eleven (100 per cent) and in the experimental
group similarly treated, but with added thymine six of eleven (55 per cent) had
mammary cancer. Mean tumour induction time and number of tumours in the
two groups were comparable.
The protective effect of thymine was confirmed by another experiment (Table
IV), in which thymine and uracil, were tested separately in 30-day old rats fed
15 mg. DMBA at fortnightly intervals for 3 doses. This dosage regimen was
selected since it induces multiple tumours in the shortest period of time, and so
TABLE IV.-Influence of Thymine and Uracil on Carcinogenic Response to DMBA.
Female Rats, Age 30 Days, were Fed i5 mg. DMBA by Gastric Tube at
Fortnightly Intervals for 3 Doses
Mammary Tumour induction time
Number eancer. (days) Number of
of Number , - - - - tumours*
rats Diet of rats M. --S.E.M. Aledian Range M.±S.E.M.
18 . 20% Protein 18 48-6±3-8 43 35-91 5-6±0-99
21 20% Protein+j1*5°/ 18 58-2±4-1 57 33-96 3- 7±0 89
Uracilt
20 . 20% Protein+1-5% 16 61±4 69 37-91 . 3-7±1-03
Thyminet
* Number of tumours at autopsy 100 days after first dose of DMBA.
t Dry weight.
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may be considered a more rigid test for anticarcinogenic agents. Although the
proportion of rats with cancer was only slightly reduced, the longer mean tumour
induction time (uracil group, P 01-0'05 and thymine group P 0 02-0*01) and re-
duced number of tumours per rat, considered with the fact that 47 (100 per cent)
control rats in three separate experiments had mammary cancer within 99 days
indicate that the protective effect of these pyrimidines is limited but real.
The response to multiple doses of DMBA by five strains of rats given their
first feeding of carcinogen at 50 days of age are presented in Table V. Sprague-
TABLE V.-Mammary Cancer in Four Strains of Rats. DMBA was Administered
by Gastric Tube to Female Rats, Age 50 Days, at Fortnightly Intervals, for
3 Doses
Mammary cancer Induction time Z- (days) Number of
Dose Number - -- tumours*
Strain (mg.) of rats % M. ±S.E.M. Median Range M. 4S.E.M.
August . . 10 . 9/10 90 91*9+4-5 90 74-107 20±04
Wistar . 15 11/11 100 47-0±241 50 40-59 . 11 0±0 99
Sprague-Dawley 15 . 11/12 92 . 58*3±5*3 51 31-80 . 8*3±154
Chester Beatty . 15 . 9/10 90 74-5+10-4 63 35-119 . 2'8+±145
Marshall. . 10 . 0/5 0 - -
* Number of tumours was determined by inspection at autopsy 60 days following appearance of
first palpable tumour.
Dawley, Wistar and Chester Beatty rats were fed 15 mg., August and Marshall
strains were fed 10 mg. to correct for their low body weight. With the exception
of Marshall rats, a high incidence of mammary cancer was observed in all strains.
The variation in response cannot be attributed to dose, since August and Marshall
rats received the highest dose when considered on a body weight basis. It is
unlikely that the differences are due to variation in maturation time, as vaginal
oestrus occurred in all Sprague-Dawley rats by 56, Wistar rats by 60, August rats
by 70, Marshall rats by 63, and Chester Beatty rats by 35 days. With due con-
sideration for dose-body weight ratios and the assumption that mean tumour
induction time and number of tumours induced are valid parameters of sensitivity
to chemical carcinogens, it is estimated that the order of sensitivity was Wistar>
Sprague-Dawley>Chester Beatty>August>Marshall. The number of Marshall
rats in this experiment is too few for a high degree of significance but they support
unpublished observations that this strain of rats exhibits resistance to the carcino-
genic effects of DMBA and 3-MC.
2. Leukaemia.-Leukaemic infiltration of kidneys, liver and spleen occurred
in 10-20 per cent of the rats in each experimental group with the exception of
the group given 3 doses each of 133 mg./kg. DMBA (Table III), in which the
incidence was 40 per cent.
3. Other toxic effects.-DMBA in the doses employed interfered with the normal
weight gain. This effect was most pronounced in the 50-day age group fed protein
diet and was related to the dose (Fig. 1 and 2).
The most common toxic effect was anaemia which became apparent within a
week after the second dose of DMBA. As a general rule the anaemia was not
severe and recovery was spontaneous. In a few instances when large doses were
given, anaemia was severe and death ensued. The highest incidence of anaemia
occurred in August strain; all rats exhibited marked pallor for several weeks.
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Microscopic examination of the adrenals revealed calcification in two instance.
One Sprague-Dawley and one Wistar rat had small calcareous deposits in their
adrenal glands. This result was unexpected, since Huggins and Morii (1961)
reporte.d a high incidence of adrenal calcification in Sprague-Dawley rats given a
single feeding of DMBA.
FIG. 1.-Growth of female Chester Beatty rats given DMBA by stomach tube on the 30th,
44th and 58th day of life.
[l] r[i Stock diet ad libitum + arachis oil.
O-- --O 20 ,, ,, ,, + DMBA 15 mg. in arachis oil.
* * 20 per cent protein diet + arachis oil
A - A ,, ,,,, ,, ,, + DMBA 6 6 mg. in arachis oil.
*----- ,,,,,, ,, , + , 15 mg. . .. .
Intraperitoneal injections
The effects of intraperitoneal injection of DMBA or 3-MC are presented in
Table VI. All rats given 15 mg. DMBA (133 mg./kg.) died between the tenth and
TABLE VI.-Tumour Induction in Female Rats given
3 MC or DMBA Intraperitoneally
Treatment
DMBA 133 mg./kg. (1 dose)
,, 60 mg./kg. (2 doses)
,, 50 mg./kg. (1 dose)
3-MC 133 mg./kg. (2 doses)
Number of
rats dying
(survival time)
12 (14 days)
11 (26 days)
4 (33-48 days)
Rats with
mammary
cancer
Rats with
sarcomata
None . None
9* .1 v1
* Mean indication time = 116 days.
Number
of
rats
12
11
12
13
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fourteenth day as a result of severe peritonitis characterized by inanition and
haemorrhagic ascites. All rats given two doses of 60 mg/kg. with a fortnightly
interval between doses died within 26 days. Ascites was first observed 48 hours
after the second dose of DMBA. On necropsy cloudy ascitic fluid, haemorrhagic
adrenals, pneumonitis and inanition were observed. A single dose of 50 mg./kg.
produced no signs of toxicity but induced no detectable tumours in 150 days at
which time all surviving rats were killed. Four of 13 animals injected twice with
30O.-~ ~ ~ ~ ~ ~ ~ ~~~~~~~~~ 0
A* '4 1 p.
FiG. 2.-Growth of female Chester Beatty rats given DMBA by stomach tube on the 50th,
64th and 78th day of life.
[] ~F Stock dliet ad libitum + arachis oil.
-- --20 ,3, ,, ,, + DMBA 15 mg. in arachis oil.
20U per cent protein diet + arachis oil.
-----05-1 ,,,,,. + DMBA 15 mg. in arachis oil.
A- - A ,,9,,9,,9 + DMBA 13-6 mg./l00 g. B.W. in arachis oil.
3-MC (133 mg./kg.) with a fortnightly interval between doses, died as a result of
anaemia in 33 to 48 days. Nine rats survived and developed fibrosarcomata
which were distributed as follows:
6 rats: fibrosarcomata of abdominal wall. These tumours were
extra-abdominal in location and appeared to originate in the midline fascia
at the point of needie entry.
5 rats: fibrosarcomata originating from the abdominal surface of the
diaphragm.
2 rats: fibrosarcomata originating at the porta hepatis.
1 rat: liposarcoma ofretroperitoneal fat.
1 rat: unclassified tumour on external surface of bladder.
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All animals in this group had multiple tumours; metastases to liver and/or spleen
were present in seven. Mammary cancer was not observed in any of these rats.
Control animals injected with arachis oil showed no signs of toxicity and no
tumours were detected at autopsy.
Administration of either naphthalene or DMBA to rats induced increases in
ascorbic acid excretion (Table VII). The effect with naphthalene was immediate
TABLE VIJ.-Effect ofAdministration ofHydrocarbons on Ascorbic Acid Excretion
in Female Rats ofDifferent Strains.
Ascorbic acid excretion
mg. per rat per day. Figures
in brackets indicate days of
maximal excretion following
Dose levels of treatment
hydrocarbon -
Body (mg./kg.) After Ist After 2nd
wt. - -A- - Before treatment treatment
mean Ist 2nd treatment highest highest
Strain Treatment (g.) treatment treatment (mean) value value
Chester Beatty . Arachis oil 186 - 1.1 2-1 (6) 2-6 (2)
DMBA oral 174 94 150 . 1.1 1 9 (6) 5-1 (3)
DMBA i.p. 184 47 80 0.8 2-2 (6) 2.9 (3)
Naphtha- . 156 500 500 1.1 3.1 (1) 3.2 (1)
lene oral
Sprague-Dawley Arachis oil . 170 .. 5 1-8 (4) 1-7 (5)
DMBAoral . 163 94 176 0 8 3.3 (4) 3.1 (5)
Naphtha- 174 500 500 14 3.9 (1) 4.2 (1)
lene oral
Marshall . Arachis oil 97 - . 0-8 1.7 (4) 1.5 (5)
DMBAoral 107 150 150 13 2.5 (5) 3.2 (2)
Naphtha- 107 . 500 500 11 1.5 (2) 2.7 (1)
lene oral
With Chester Beatty strain rats each group consisted of 6 rats, 37 days old.
With Sprague-Dawley and Marshall strain rats each group consisted of 4 rats, 50 days old.
i.p. = intraperitoneal injection.
and ofshort duration and similar to that induced by phenobarbitone described by
Longenecker, Fricke and King (1940). The effect with DMBA was delayed and
prolonged and similar to that described by Allen and Boyland (1957), Boyland and
Grover (1961), and Conney and Burns (1959). The increase in ascorbic acid
excretion produced by either hydrocarbon was greater in the Chester Beatty and
Sprague-Dawley rats (strains which develop mammary cancer on treatment with
DMBA) than in the Marshall strain rats (which did not develop mammary cancer).
The Marshall strain rats were given bigger doses (when expressed on a body
weight basis) than either of the other strains.
DISCUSSION
The mammary tumours induced in rats by oral administration of polycyclic
hydrocarbons are remarkable in that they often appear more quickly than do
other tumours induced by these compounds. Boyland (1962) has suggested that
the rapid induction might be due to the compounds destroying a suppressor
737E. BOYLAND AND K. L. SYDNOR
substance analogous to the bacterial suppressor described by Monod (1961), which
controls the development of phage and of certain enzymes. The mammary
tumours which arise in a few weeks in rats might be due to the carcinogen destroy-
ing a suppressor normally present in the rat tissues which controls development
ofa virus or similar agent. The tumour might then develop as the result ofrelease
or activation of this agent. The fact that mammary tumours are not induced in
the Marshall strains could be due to absence ofthe agent in that strain.
The administration of carcinogenic hydrocarbons to young rats increases the
activity of a number ofmicrosomal enzymes which metabolise foreign compounds
including the carcinogenic hydrocarbons themselves (Conney, Miller and Miller,
1957). They also cause an increase in liver ascorbic acid (Daff, Hoch-Ligetti,
Kennaway and Tipler, 1948), and ascorbic acid excretion (Allen and Boyland,
1957). Boyland (1962) also suggested that these effects of increased enzyme
activity might similarly be due to inactivation by the carcinogens of suppressor
factors which normally control the production ofthese enzymes in the liver. The
Marshall strain rats gave a smaller increase in ascorbic acid excretion than did
rats ofthe other strains on treatment with either DMBA or with naphthalene and
this effect might be associated with the carcinogenic action in some way.
The urine of rats of each strain treated with naphthalene, or DMBA was exa-
mined for metabolites and no qualitative differences between strains were observed
(Sims, personal communication). It is unlikely that the difference in carcinogenic
response in the strains is due to differences in metabolism of hydrocarbons in the
strains.
The effect of the pyrimidines, thymine and uracil in reducing the carcinogenic
action of DMBA although small appears to be definite. Boyland and Koller
(1954) showed that administration of thymine to rats reduced the amount of
chromosome damage caused by urethane. Rogers (1957) found that thymine
(and uracil to a lesser extent) reduced the incidence of lung adenomas in
mice treated with urethane. Rogers (1960) also showed that the carcinogenic
effect of methylcholanthrene on the lung was reduced by feeding pyrimidines.
The results of the present paper show that the anticarcinogenic action of the
natural pyrimidines is perhaps a general phenomenon.
SUMMARY
1. The forced feeding of oil solutions of 7,12-dimethylbenz(a)anthracene
(DMBA) to female rats of Sprague-Dawley or Wistar strains induced multiple
mammary tumours in 4 to 6 weeks. The same treatment does not induce mam-
mary cancerinrats ofthe Marshall strain and onlyafterlongerperiodsinratsofthe
August strain.
2. Intraperitoneal injection ofthe same hydrocarbon does not induce the mam-
mary tumours.
3. Oral administration of DMBA or naphthalene increases ascorbic acid
excretion of rats to a greater extent in Sprague-Dawley and Chester Beatty
strain rats than in Marshall strain rats.
4. The induction of mammary cancer by DMBA was partially neutralised
by feeding thymine or uracil.
5. Administration of DMBA reduced the growth of female Chester Beatty
strain rats maintained on a 20 per cent protein dietif treatment started when the
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rats were 50 days. The growth inhibition was less if treatment started at 30
days, or ifthe rats were maintained on the stock rat cake diet.
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